Engineering specific enzymatic variants that combine transcriptional regulation with phosphoribosyltransferase activity. This controls the metabolic flux of the purine biosynthetic pathway to maximize 5'-inosine monophosphate yields.
Natural transcriptional regulators and phosphoribosyltransferases are subject to strict feedback inhibition that limits industrial metabolite yields. Overcoming these regulatory bottlenecks allows for the hyper-production of 5'-inosinic acid and guanylic acid.